Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$95.02

0.1 (0.11%)

06:39
04/16/19
04/16
06:39
04/16/19
06:39

Exact Sciences price target raised to $115 from $109 at UBS

UBS analyst Dan Brennan raised his price target on Exact Sciences to $115 and kept his Buy rating. The analyst cites his findings of the UBS Evidence Lab's survey of 150 doctors to gauge the outlook for Cologuard and sees the results as "quite positive" in terms of the level of testing per doctor that "reflects significant upside potential." Brennan adds that he sees the expected market share for Cologuard at "over 50% ahead of what's implied in his forecasts" when looking further out to 2023.

  • 30

    Apr

  • 18

    May

  • 05

    Jun

  • 06

    Aug

EXAS Exact Sciences
$95.02

0.1 (0.11%)

04/12/19
04/12/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Martin Marietta (MLM) upgraded to Buy from Neutral at Goldman Sachs analyst Jerry Revich saying he is positive on an inflection in the aggregates pricing cycle, an acceleration in infrastructure capital expenditures, and potential return to a "steady recovery" for residential construction in 2020-2021. 2. Adient (ADNT) upgraded to Buy from Neutral at BofA/Merrill with analyst John Murphy saying he believes Adient is in the process of refinancing its debt, despite investor concerns of a potential liquidity crunch, which would allow it to execute on its turnaround. 3. Exact Sciences (EXAS) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Patrick Donnelly citing his view that the stock is set-up well for the remainder of 2019. 4. Delphi Technologies (DLPH) upgraded to Buy from Neutral at BofA/Merrill with analyst John Murphy saying new CEO Rick Dauch's business review will come to a close in mid-April and expects more formal and constructive updates around Delphi's transformation plan. 5. Murphy Oil (MUR) upgraded to Neutral from Sell at Goldman Sachs with analyst John Murphy saying he believes Adient is in the process of refinancing its debt, despite investor concerns of a potential liquidity crunch, which would allow it to execute on its turnaround. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/19
GSCO
04/12/19
UPGRADE
Target $120
GSCO
Conviction Buy
Exact Sciences upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Patrick Donnelly added Exact Sciences to the firm's Americas Conviction List, citing his view that the stock is set-up well for the remainder of 2019. Cologuard is a unique growth story, competing liquid biopsy products are likely years away from commercial launches and optionality from pipeline products is currently underappreciated, Donnelly tells investors. He keeps a $120 price target on Exact Sciences shares.
03/04/19
BARD
03/04/19
NO CHANGE
Target $102
BARD
Outperform
Aetna lowering of screening age positive for Exact Sciences, says Baird
CVS Health (CVS) unit Aetna on Friday revised its policy to state that colorectal cancer screening is considered medically necessary for average-risk persons aged 45 years and older when recommended by their physician, Baird analyst Catherine Ramsey Schulte tells investors in a research note. Aetna's previous version covered for average-risk persons beginning at age 50 years, the analyst points out. While admitting further uptake in ages 45-49 will require medical education among doctors, Ramsey Schulte views Aetne'a update as "incrementally positive" for Exact Sciences. She keeps an Outperform rating on the shares with a $102 price target. The stock in early trading is up 1% to $93.57.
02/26/19
02/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Exact Sciences (EXAS) upgraded to Buy from Neutral at Goldman Sachs by analyst Patrick Donnelly, who said the current momentum of the Cologuard commercial ramp provides "strong basis" for the company's premium valuation while the combination of positive Cologuard catalysts and new product roll-outs provide upside to current levels, even after the stock's 75% rally since the beginning of 2018. Exact Sciences is a "must-own growth stock" given the "clean runway forward that is largely in its control with potential for discovery value in the pipeline outside of Cologuard," the analyst said. 2. Siemens (SIEGY) upgraded to Overweight from Neutral at JPMorgan by analyst Andreas Willi, who sees a relative valuation opportunity after the stock's 27% underperformance over the past two years. He believes investor sentiment can improve "after a period where the story has drifted." 3. Kadmon (KDMN) upgraded to Buy from Neutral at Citi by analyst Robyn Karnauskas, who assigned a 50% probability to KD-025 in chronic graft versus host disease with an unadjusted ~$900M market opportunity. However, upside to the stock will depend on quality of the data likely, Karnauskas said. 4. EverQuote (EVER) upgraded to Buy following Q4 beat at BofA/Merrill by analyst Mat Schindler, who said user growth has re-accelerated, supporting evidence of a turnaround, and thinks estimates are conservative and views the risk/reward as attractive. 5. Ally Financial (ALLY) upgraded to Buy from Hold at Sandler O'Neill by analyst Christopher Donat, who said he believes Ally's near-prime auto finance book is "meaningfully less risky" than Santander Consumer's (SC) book or the unsecured credit cards of Discover (DFS) and Capital One (COF), yet all four stocks trade at similar multiples. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NXPI

NXP Semiconductors

$90.85

-2.79 (-2.98%)

14:45
05/23/19
05/23
14:45
05/23/19
14:45
Options
NXP Semiconductors call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 13

    Jun

FE

FirstEnergy

$42.94

0.31 (0.73%)

14:36
05/23/19
05/23
14:36
05/23/19
14:36
Periodicals
Breaking Periodicals news story on FirstEnergy »

Ohio advances bill that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$202.83

-6.34 (-3.03%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Hot Stocks
Huntington Ingalls VP William Ermatinger sells almost $400K in company shares »

Huntington Ingalls VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

QRVO

Qorvo

$59.38

-0.83 (-1.38%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Options
Qorvo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UIS

Unisys

$9.44

-0.3 (-3.08%)

14:31
05/23/19
05/23
14:31
05/23/19
14:31
Initiation
Unisys initiated  »

Unisys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MAXR

Maxar Technologies

$8.20

1.05 (14.69%)

14:28
05/23/19
05/23
14:28
05/23/19
14:28
Hot Stocks
NASA confirms contract with maximum $375M value awarded to Maxar Technologies »

NASA announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$40.84

-0.86 (-2.06%)

, PLD

Prologis

$76.02

-0.55 (-0.72%)

14:27
05/23/19
05/23
14:27
05/23/19
14:27
Periodicals
Blackstone, Prologis separately bidding for U.S. unit of GLP, WSJ says »

Blackstone (BX) and…

BX

Blackstone

$40.84

-0.86 (-2.06%)

PLD

Prologis

$76.02

-0.55 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

GLNG

Golar LNG

$19.17

-0.82 (-4.10%)

14:25
05/23/19
05/23
14:25
05/23/19
14:25
Options
Golar LNG call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$107.68

-3.11 (-2.81%)

14:24
05/23/19
05/23
14:24
05/23/19
14:24
Periodicals
JPMorgan severs ties with OxyContin maker Purdue Pharma, Reuters says »

JPMorgan has severed ties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 16

    Jul

MAXR

Maxar Technologies

$8.04

0.89 (12.45%)

14:18
05/23/19
05/23
14:18
05/23/19
14:18
Hot Stocks
Breaking Hot Stocks news story on Maxar Technologies »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
05/23/19
05/23
14:17
05/23/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$53.15

-1.05 (-1.94%)

14:16
05/23/19
05/23
14:16
05/23/19
14:16
Recommendations
Foot Locker analyst commentary at Canaccord »

Canaccord says buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
05/23/19
05/23
14:16
05/23/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
05/23/19
05/23
14:15
05/23/19
14:15
Conference/Events
Wolfe Research pharmaceuticals analyst to hold analyst/industry conference call »

Pharmaceuticals Analyst…

VXX

iPath S&P 500 VIX Short-Term Futures

$29.12

1.91 (7.02%)

14:10
05/23/19
05/23
14:10
05/23/19
14:10
Options
Bullish spread opened in VIX Short-term Futures Fund »

Bullish spread opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:06
05/23/19
05/23
14:06
05/23/19
14:06
Conference/Events
Wolfe Research managing director to hold an analyst/industry webinar »

Quantitative Analysis,…

MAXR

Maxar Technologies

$7.59

0.44 (6.15%)

14:06
05/23/19
05/23
14:06
05/23/19
14:06
Hot Stocks
Maxar Technologies up 17% after selection for NASA project »

Maxar Technologies shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLUU

Glu Mobile

$8.32

-0.185 (-2.18%)

14:05
05/23/19
05/23
14:05
05/23/19
14:05
Options
Glu Mobile call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 13

    Nov

MAXR

Maxar Technologies

$7.32

0.17 (2.38%)

14:03
05/23/19
05/23
14:03
05/23/19
14:03
Periodicals
NASA selects Maxar for first part of lunar gateway, WFTV reports »

Maxar Technologies was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$40.90

-0.8 (-1.92%)

, PLD

Prologis

$76.22

-0.35 (-0.46%)

14:00
05/23/19
05/23
14:00
05/23/19
14:00
Periodicals
Breaking Periodicals news story on Blackstone, Prologis »

Blackstone, Prologis bid…

BX

Blackstone

$40.90

-0.8 (-1.92%)

PLD

Prologis

$76.22

-0.35 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

BX

Blackstone

$40.90

-0.8 (-1.92%)

, PLD

Prologis

$76.22

-0.35 (-0.46%)

13:59
05/23/19
05/23
13:59
05/23/19
13:59
Periodicals
Breaking Periodicals news story on Blackstone, Prologis »

Blackstone, Prologis…

BX

Blackstone

$40.90

-0.8 (-1.92%)

PLD

Prologis

$76.22

-0.35 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

MAXR

Maxar Technologies

$7.00

-0.15 (-2.10%)

13:56
05/23/19
05/23
13:56
05/23/19
13:56
Periodicals
Breaking Periodicals news story on Maxar Technologies »

Maxar selected by NASA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$37.86

-0.96 (-2.47%)

13:55
05/23/19
05/23
13:55
05/23/19
13:55
Options
Taiwan Semi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BB

BlackBerry

$8.05

-0.26 (-3.13%)

13:45
05/23/19
05/23
13:45
05/23/19
13:45
Options
BlackBerry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
05/23/19
05/23
13:45
05/23/19
13:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY fell…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.